BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//wp-events-plugin.com//7.2.3.1//EN
BEGIN:VEVENT
UID:7491@myasthenia.org
DTSTART;TZID=America/New_York:20250909T140000
DTEND;TZID=America/New_York:20250909T140000
DTSTAMP:20250828T220049Z
URL:https://myasthenia.org/events/webinar-add-on-muscle-targeted-therapy-f
 or-generalized-myasthenia-gravis-introduction-to-nmd670/
SUMMARY:Webinar: Add-On Muscle-Targeted Therapy for Generalized Myasthenia 
 Gravis: Introduction to NMD670
DESCRIPTION:Tuesday\, September 9\, 2025 2:00 PM Eastern Time / 11:00 AM Pa
 cific Time\nPresenters:\nJames F. Howard\, Jr.\, MD\, FAAN – Professor o
 f Neurology\, Medicine &amp\; Allied HealthDirector\, Myasthenia Gravis Cl
 inical Trials and Translational Research Program\, The University of North
  Carolina at Chapel Hill \nThomas S. Grønnebæk\, PhD – Principal Clin
 ical Scientist at NMD Pharma A/S \nVera Kiyasova\, MD\, PhD – Clinical 
 Development Director at NMD Pharma A/S \nJoin us to learn about new add-o
 n\, muscle-targeted therapy\, a novel oral medication that is being develo
 ped by NMD Pharma for generalized myasthenia gravis. NMD Pharma's clinical
  team\, together with Dr. Howard\, will explain how this molecule works an
 d the science behind it\, and will introduce the ongoing clinical trial an
 d how you can join. \nRegister\nAfter registering\, you will receive a co
 nfirmation email containing information about joining the webinar. \n\n\n
 This webinar is made possible by NMD Pharma.\n
ATTACH;FMTTYPE=image/jpeg:https://myasthenia.org/wp-content/uploads/2025/0
 8/NMD670-thumbnail-1.png
CATEGORIES:Events,Webinars
END:VEVENT
BEGIN:VTIMEZONE
TZID:America/New_York
X-LIC-LOCATION:America/New_York
BEGIN:DAYLIGHT
DTSTART:20250309T030000
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
END:DAYLIGHT
END:VTIMEZONE
END:VCALENDAR